Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications
The coronavirus disease 2019 (COVID-19) epidemic is currently raging around the world at a rapid speed. Among COVID-19 patients, SARS-CoV-2-associated acute respiratory distress syndrome (ARDS) is the main contribution to the high ratio of morbidity and mortality. However, clinical manifestations be...
Main Authors: | Ching-Tse Ting, Bor-Sen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/7/3649 |
Similar Items
-
Genetic and Epigenetic Host–Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach
by: Bo-Wei Hsu, et al.
Published: (2023-05-01) -
Endothelial Damage in Acute Respiratory Distress Syndrome
by: Alice G. Vassiliou, et al.
Published: (2020-11-01) -
Genetic Determinants of the Acute Respiratory Distress Syndrome
by: Eva Suarez-Pajes, et al.
Published: (2023-05-01) -
Hypertonic treatment of acute respiratory distress syndrome
by: Weiyu Li, et al.
Published: (2023-10-01) -
Role of Macrophage Polarization in Acute Respiratory Distress Syndrome
by: Priyanka Mishra, et al.
Published: (2021-11-01)